logo-loader

Nephros raises US$2.9mln; puts listing on national exchange in its sights

Published: 09:27 11 Apr 2018 EDT

Nephros, Inc (OTCQB:NEPH) CFO Andy Astor tells Proactive Investors the medical-device company is taking in a US$2.9mln private placement.

Astor says the money will be used to shore up the company's balance sheet, potentially getting it to the point where it can up-list to a national exchange, as well as manage growth, increase inventory, and possibly pursue strategic opportunities.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 5 minutes ago